|
|
The Future of Clinical Research in HCT: Reports from the 2007 State of the Science Symposium (Slides)These slides are from the NMDP sponsored symposium held December 7, 2007, prior to the American Society of Hematology (ASH) Annual Meeting.Review SlidesSymposium Slides (PDF)No CME Credit Available Program DescriptionThe field of hematopoietic cell transplantation (HCT) has advanced significantly, now with an estimated 45,000 patients treated worldwide each year. Reasons for the increased use include proven efficacy in many diseases, better understanding of appropriate timing and patient selection, improved availability of donors and cord blood units and determining HLA match, and improved supportive care. Despite these improvements, application of HCT can be limited by risks of morbidity and mortality. Further progress will require design and implementation of additional high impact HCT clinical trials.These slides present the conclusions from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 2007 State of the Science Symposium. This conference brought together leaders in the field who intensively evaluated scientific advances and challenges in each of twelve areas of focus. These slides present, for the first time, their recommendations for translational and clinical research studies most likely to advance the field. FacultyJames Ferrara, M.D., Mary Horowitz, M.D., Dennis Confer, M.D., Daniel Weisdorf, M.D., Joseph Antin, M.D.Learning Objectives
QuestionsIf you have any questions regarding these slides, call Renee Ryan at (800) 526-7809 ext. 8430. |
|
||